Skip to main content
Caplight Logo









Iceni Glycoscience

Iceni Glycoscience

Private
NorwichHealthcare & Life Scienceshttp://iceniglycoscience.com/

Last Round

Grant

Mar 1, 2021

Total Funding Raised

$3.06M

Company Overview

Iceni Glycoscience is a biotechnology company that develops carbohydrate-based therapeutics and diagnostic technologies for infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

glycoscienceglycobiologycarbohydrate chemistryinfectious disease diagnosticspoint-of-care testingglycoengineeringcontract researchdiagnostic platformpathogen detectionvaccine alternativesantibiotic alternativeswet-lab servicesbiotech R&Dlateral-flow testsdrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Iceni Glycoscience Comparables

Compare Iceni Glycoscience with similar companies based on industry and business-model similarity.

Iceni Glycoscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Glycan Therapeutics
74%
GlycoT Therapeutics
72%
GlyTech, Inc.
69%

Iceni Glycoscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 1, 2021
SeedDec 17, 2020
Early FundingOct 1, 2018
SeedOct 1, 2016

Iceni Glycoscience Investors

Notable investors and investment history

Iceni Glycoscience investors
InvestorRounds
Marie Skłodowska-Curie ActionsGrant
Anglia Capital GroupSeed, Early Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 27, 2025

    Monthly visitors grew 33% MoM.

  • Oct 1, 2016

    Completed a Seed funding round.

Iceni Glycoscience Filings

Explore SEC and related filing metadata, where available.

Iceni Glycoscience filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Iceni Glycoscience's valuation, stock price, and market status.

Is Iceni Glycoscience a public or private company?

Iceni Glycoscience is a private company.

What is the current stock price of Iceni Glycoscience?

Iceni Glycoscience is a private company, so its shares have no public market price. Caplight tracks Iceni Glycoscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Iceni Glycoscience worth (valuation)?

Valuation information for Iceni Glycoscience is not publicly available.

Can I buy Iceni Glycoscience stock?

Iceni Glycoscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Iceni Glycoscience's last funding round?

Iceni Glycoscience's most recent funding round was Grant on March 1, 2021.

Who are the main investors in Iceni Glycoscience?

Key investors in Iceni Glycoscience include Marie Skłodowska-Curie Actions, Anglia Capital Group.

Will Iceni Glycoscience IPO soon?

No public IPO plans have been announced for Iceni Glycoscience.

How can I track Iceni Glycoscience secondary market activity?

Caplight tracks bids, offers, and trades in Iceni Glycoscience's shares on secondary markets.

Firmographic Details

HeadquartersNorwich
Employee Range3
Year Founded2014
Last FundingMar 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?